yutaka-tokuda documents

A malignant cystosarcoma phyllodes with positive estrogen receptor and its heterotransplantation into nude mice
Documents A malignant cystosarcoma phyllodes with positive estrogen receptor and its heterotransplantation into nude mice
Isochronal annealing study of hydrogen interaction with implantation-induced point defects in p-type silicon
Documents Isochronal annealing study of hydrogen interaction with implantation-induced point defects in p-type silicon
Isothermal deep-level transient spectroscopy study of metastable defects in hydrogen-implanted n-type silicon
Documents Isothermal deep-level transient spectroscopy study of metastable defects in hydrogen-implanted n-type silicon
Annihilation and formation of electron traps in hydrogen-implanted n-type silicon by light illumination
Documents Annihilation and formation of electron traps in hydrogen-implanted n-type silicon by light illumination
Evaluation of dislocation-related defects in GaN using deep-level transient spectroscopy
Documents Evaluation of dislocation-related defects in GaN using deep-level transient spectroscopy
Hole traps in n-GaN detected by minority carrier transient spectroscopy
Documents Hole traps in n-GaN detected by minority carrier transient spectroscopy
Compassionate use of humanized anti-HER2/ neu protein, trastuzumab for metastatic breast cancer in Japan
Documents Compassionate use of humanized anti-HER2/ neu protein, trastuzumab for metastatic breast cancer in Japan
Antibodies as molecular target-based therapy: trastuzumab
Documents Antibodies as molecular target-based therapy: trastuzumab
The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review
Documents The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review
Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208
Documents Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208
A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance
Documents A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance
Mixed Reality Projection Display
Documents Mixed Reality Projection Display